Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Scientific Reports|August 2, 2019
Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteersChristian Schoergenhofer, Nina Buchtele, Georg Gelbenegger, et al.Lancet (London, England)|November 10, 2018
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trialEmil C Reisinger, Roland Tschismarov, Eckhard Beubler, et al.The Lancet. Infectious Diseases|June 15, 2016
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trialMichael Schwameis, Bernhard Roppenser, Christa Firbas, et al.Shock (Augusta, Ga.)|July 4, 2008
Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemiaFlorian B Mayr, Christa Firbas, Judith M Leitner, et al.The Lancet. Infectious Diseases|March 6, 2015
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trialKatrin Ramsauer, Michael Schwameis, Christa Firbas, et al.Research and Practice in Thrombosis and Haemostasis|September 13, 2024
Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisonsUlla Derhaschnig, Nina Buchtele, Margarete M Steiner, et al.Scientific Reports|July 21, 2021
Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humansKarolina Samekova, Christa Firbas, Johanna Irrgeher, et al.Clinical Pharmacology and Therapeutics|May 9, 2018
A Randomized, First-in-Human, Healthy Volunteer Trial of sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement PathwayJohann Bartko, Christian Schoergenhofer, Michael Schwameis, et al.British Journal of Clinical Pharmacology|March 8, 2020
Dose-dependent naloxone-induced morphine withdrawal symptoms in opioid-dependent males-a double-blinded, randomized studyStefan Weisshaar, Laura Brandt, Brigitte Litschauer, et al.Vaccine|February 4, 2011
Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51Susanne Eder, Katrin Dubischar-Kastner, Christa Firbas, et al.Pageof 5